A retrospective Taiwanese study in operable gastric adenocarcinoma patients found IL-6 to be an independent prognostic factor for OS, although patients were treated between 1999 and 2002, prior to the widespread adoption of perioperative chemotherapy [40]. This evidence concerns the gene IL6 and gastric adenocarcinoma.